🛡️ Public data only — no PHI permitted on this instance.
SC
SeekingChartis
Investment Committee Memorandum | FL | 85 beds | Grade C | EBITDA uplift $3.2M
Investment Committee Memorandum

WEST GABLES REHABILITATION HOSPITAL

CCN 103036 | MIAMI-DADE, FL | 85 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

WEST GABLES REHABILITATION HOSPITAL is a 85-bed suburban community hospital in MIAMI-DADE, FL with $43.6M in net patient revenue and a 1.8% operating margin. The hospital serves a payer mix of 48.5% Medicare, 2.5% Medicaid, and 49.0% commercial.

Thesis: Turnaround. Our ML models identify $3.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 1.8% to 9.1% (+736bps).

Net Revenue HCRIS$43.6M
Current EBITDA COMPUTED$773K
Operating Margin COMPUTED1.8%
Occupancy HCRIS90.1%
Revenue / Bed COMPUTED$513K
Net-to-Gross HCRIS29.8%
Distress Probability ML40.4%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
119
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 1.8% places it below the state median. Among 119 size-comparable peers (42-170 beds), the median margin is 2.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (42-170), prioritizing same-state peers. 119 hospitals in the comp set.

HospitalStateBedsRevenueMargin
WEST GABLES REHABILITATION HOS (Target)FL85$43.6M1.8%
WEST KENDALL BAPTIST HOSPITALFL127$361.6M18.5%
ADVENTHEALTH WESLEY CHAPELFL169$360.1M17.0%
ORLANDO HEALTH SOUTH LAKE HOSPFL167$331.8M7.2%
ADVENTHEALTH PALM COASTFL99$285.7M8.1%
HOMESTEAD HOSPITALFL159$270.4M-11.1%
NEMOURS CHILDRENS HOSPITALFL130$268.7M-10.2%
DOCTORS HOSPITALFL130$250.0M0.9%
ADVENTHEALTH ZEPHYRHILLSFL149$207.1M-0.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$916K+210bp18mo
Cost to Collect4.5%2.5%$872K+200bp12mo
Denial Rate Reduction12.0%6.5%$864K+198bp12mo
A/R Days Reduction5200.0%3800.0%$531K+122bp9mo
Clean Claim Rate88.0%96.0%$28K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$916K
Cost to Collect
$872K
Denial Rate Reduction
$864K
A/R Days Reduction
$531K
Clean Claim Rate
$28K
Total EBITDA Uplift$3.2M
Current EBITDA$773K
+ RCM Uplift+$3.2M
Pro Forma EBITDA$4.0M
Current Margin1.8%
Pro Forma Margin9.1%
WC Released (1x)$1.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$1.2M$37.2M31.27x99.1%
Base (11x exit)10.0x11.0x$1.2M$41.3M34.73x103.3%
Bull Case9.0x11.0x$1.1M$52.3M48.84x117.7%
Bull (12x exit)9.0x12.0x$1.1M$57.4M53.58x121.7%
Bear Case11.0x10.0x$1.3M$20.8M15.87x73.8%
Bear (11x exit)11.0x11.0x$1.3M$23.3M17.78x77.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 119 hospitals with 42-170 beds
  • Same-state prioritization (n=120)
  • Comp margins: P25=-9.0% / P50=2.8% / P75=12.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.

Full EBITDA BridgeML AnalysisHospital ProfileStatistical ProfileDeal Screener